NASDAQ:ADTX

Aditx Therapeutics Stock Forecast

etoro logo Buy ADTX
*Your capital is at risk
$0.0026
-0.0004 (-13.33%)
At Close: Aug 10, 2026

Should you buy ADTX stock?

Last updated:

Based on market data through , StockInvest.us rates ADiTx Therapeutics, Inc. (ADTX) as a Strong Sell Candidate with a technical score of -6.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 56.67%
  • 3-month trend forecast Down 99.49%
  • Strong Sell Candidate -6.00
AI Analysis AI Analysis of ADTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ADTX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

ADiTx Therapeutics, Inc. stock price fell more than -13.33% Monday closing at $0.0026
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 30, 2026 Loss -56.67%

The ADiTx Therapeutics, Inc. stock price fell by -13.33% on the last day (Monday, 10th Aug 2026) from $0.0030 to $0.0026. During the last trading day the stock fluctuated 8.33% from a day low at $0.0024 to a day high of $0.0026. The price has fallen in 4 of the last 10 days and is down by -18.75% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 3 million shares were bought and sold for approximately $6.86 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is -$0.137, a level that may pose a second chance to hit a runner. According to fan-theory $0.583 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ADTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ADiTx Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0028 and $0.0053. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 30, 2026, and so far it has fallen -56.67%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ADiTx Therapeutics, Inc. stock

ADiTx Therapeutics, Inc. finds support from accumulated volume at $0.0025 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0002 between high and low, or 8.33%. For the last week the stock has had daily average volatility of 10.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADTX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect ADiTx Therapeutics, Inc. to open at $0.0025, and during the day (based on 14 day Average True Range), to move between $0 and $0.0092, which gives a possible trading interval of +/-$0.0132 (+/-9 219.50%) up or down from last closing price. If ADiTx Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9 219.50% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the support from accumulated volume at $0.0025 (3.85%) than the resistance at $0.0028 (7.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ADiTx Therapeutics, Inc. stock A Buy?

ADiTx Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.000 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.0025 ( 2.56%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ADTX Performance

Trading levels for ADTX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0027 5.13%
R2 0.0027 2.19%
R1 0.0026 0.374%
Price 0.0026
S1 0.0025 -5.50%
S2 0.0024 -7.32%
S3 0.0023 -10.26%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0032 23.08%
R2 0.0030 15.38%
R1 0.0028 7.69%
Price 0.0026
S1 0.0025 -3.85%
S2 0.0024 -7.69%
S3 0.0020 -23.08%

FAQ

What is the symbol for ADiTx Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for ADiTx Therapeutics, Inc. is ADTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ADiTx Therapeutics, Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates ADiTx Therapeutics, Inc. (ADTX) as a Strong Sell Candidate with a technical score of -6.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jun 30, 2026, the price has fallen 56.67%. The current 3-month trend forecast projects a fall of 99.49%.

How to buy ADiTx Therapeutics, Inc. Stock?
ADiTx Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ADiTx Therapeutics, Inc. Stock.

What's the current price of ADiTx Therapeutics, Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an ADiTx Therapeutics, Inc. (ADTX) share was $0.0026.

What is the 52-week high and low for ADiTx Therapeutics, Inc. Stock?
The 52-week high for ADiTx Therapeutics, Inc. Stock is $1,543.32 and the 52-week low is $0.0020.

What is the market capitalization of ADiTx Therapeutics, Inc. Stock?
As of the Aug 10, 2026, the market capitalization of ADiTx Therapeutics, Inc. is 2.595M.

When is the next earnings date for ADiTx Therapeutics, Inc.?
The upcoming earnings date for ADiTx Therapeutics, Inc. is Sep 02, 2026.
Click to get the best stock tips daily for free!
ABOUT ADITX THERAPEUTICS, INC.
ADiTx Therapeutics
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body natural...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE